Oral Antibiotics for Anal Abscess

Launched by GERMANS TRIAS I PUJOL HOSPITAL · Aug 21, 2018

Keywords

ClinConnect Summary

This clinical trial is studying whether taking antibiotics after treatment for a perianal abscess (a painful infection near the anus) can help prevent the development of an anal fistula, which is an abnormal connection that can form between the anal canal and the skin. Researchers want to find out if giving patients a course of antibiotics along with their usual care will lower the chance of developing this complication, which can significantly affect a person’s quality of life.

To participate in this trial, you need to be an adult over 18 years old with a diagnosed perianal abscess. However, individuals with certain conditions, like previous abscesses, inflammatory bowel disease, or diabetes, won't be eligible. If you join the study, you will be randomly assigned to receive either antibiotics or a placebo (a sugar pill that has no effect) after your treatment. Over the next year, your health will be monitored to see if you develop an anal fistula, and your quality of life will also be assessed. This research could lead to important changes in how perianal abscesses are treated in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients over 18 years old
• • Clinical diagnosis of perianal abscess
• Exclusion Criteria:
• • Participants who have a history of previous perianal abscesses.
• • Inflammatory bowel disease
• • Patients who already have a perianal fistula
• • Patients with perianal cancer and / or pelvic radiotherapy
• • Perianal trauma
• • Immunodeficiency
• • Diabetes
• • Pregnancy or lactation
• • Valvular heart disease or prosthetic valve carriers
• • Spontaneous drainage
• • Previous use of antibiotics
• • Patients with a known allergy to Ciprofloxacin or Metronidazole.